Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q87N49

Entry ID Method Resolution Chain Position Source
AF-Q87N49-F1 Predicted AlphaFoldDB

No variants for Q87N49

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q87N49

No associated diseases with Q87N49

2 regional properties for Q87N49

Type Name Position InterPro Accession
domain Orotidine 5'-phosphate decarboxylase domain 5 - 226 IPR001754
active_site Orotidine 5'-phosphate decarboxylase, active site 57 - 70 IPR018089

Functions

Description
EC Number 4.1.1.23 Carboxy-lyases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

1 GO annotations of molecular function

Name Definition
orotidine-5'-phosphate decarboxylase activity Catalysis of the reaction: H(+) + orotidine 5'-phosphate = CO(2) + UMP.

2 GO annotations of biological process

Name Definition
'de novo' pyrimidine nucleobase biosynthetic process The chemical reactions and pathways resulting in the formation of pyrimidine nucleobases, 1,3-diazine, organic nitrogenous bases, beginning with the synthesis of a pyrimidine ring from simpler precursors.
'de novo' UMP biosynthetic process The chemical reactions and pathways resulting in the formation of UMP, uridine monophosphate, starting with the synthesis of (S)-dihydroorotate from bicarbonate; UMP biosynthesis may either occur via reduction by quinone, NAD(+) or oxygen.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MIDQKVIVAL DYDNQADALA FVDRIDPASC RLKVGKEMFT LFGPDFVREL HKRGFSVFLD
70 80 90 100 110 120
LKFHDIPNTC SKAVRAAAEL GVWMVNVHAS GGERMMTASR EILEPYGKDR PLLIGVTVLT
130 140 150 160 170 180
SMEQSDLAGI GLNVEPQEQV IRLATLTKNS GLDGVVCSAQ ESSLLKNELG KEFKLITPGI
190 200 210 220 230
RPAGSDQGDQ RRIMTPVDAI QAGSDYLVIG RPITQATDPA AVLKSINDSL ASK